Assessing quality of life in comparative cancer clinical trials: Does it make a difference?

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Many randomized Phase III trials of cancer therapy involve quality of life assessments. This paper argues for graphical presentation of quality of life measures in order to visualize changes over time.

Cite

CITATION STYLE

APA

Machin, D. (1997). Assessing quality of life in comparative cancer clinical trials: Does it make a difference? Controlled Clinical Trials, 18(4), 301–305. https://doi.org/10.1016/S0197-2456(96)00177-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free